ArticleFood science & nutrition2025
The Impact of Thermal Treatment and In Vitro Digestion on Antioxidant Activity and Anti-Glycation Properties of Antioxidant Crude Extract From Hot and Cold Brew Spent Coffee Ground.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ethanoic extract of hot-brew spent-coffee ground (HSCG) and cold-brew spent-coffee ground (CSCG) were prepared with ultrasound-assisted extraction and subjected to thermal processes and in vitro digestion prior to analyze the inhibition ability of advanced glycation end products (AGEs) formation, a potential risk factor for Alzheimer's disease. The obtained HSCG and CSCG extracts contained mainly chlorogenic acid derivatives, according to liquid chromatography-mass spectrometer chromatogram. The glycation process was performed by using bovine serum albumin (BSA)/ glucose system with 3 weeks incubation. In the presence of HSCG and CSCG extracts at 250 μg/mL, after thermal treatment (pasteurization and sterilization) and in vitro digestion, the glycation process through the fructosamine, AGEs, and amyloid cross β structure formation was monitored, and these extracts exhibited an anti-glycation property at early and advanced stages after pasteurization and in vitro digestion compared to no thermal treatment. However, at high temperature of sterilization, the suppress of anti-glycation property had resulted and were related with the amount of antioxidant and the ability of antioxidant scavenging as presented in a dose manner. The calculated % caffeine bio-accessibility of HSGC extracts was 65.8%, 64.8%, and 52.4% in non-thermal, pasteurized, and sterilized samples while the higher bio-accessibility was found in CSCG sample as of 67.4, 66.6, and 63.1, respectively. A high correlation of TPC values, thermal treatments and in vitro digestions with the AGEs was detected. Polyphenols and caffeine content in these extracts were found to be responsible for the AGEs and amyloid cross β structure inhibition which might potentially reduce the risk of Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.